ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 162 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2018. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $82,410 | -76.7% | 51,830 | -8.5% | 0.00% | -100.0% |
| Q4 2022 | $352,967 | +8.9% | 56,656 | +17.1% | 0.00% | 0.0% |
| Q3 2022 | $324,000 | -63.1% | 48,392 | -65.0% | 0.00% | -50.0% |
| Q2 2022 | $879,000 | +77.9% | 138,257 | +29.8% | 0.00% | +100.0% |
| Q1 2022 | $494,000 | +17.9% | 106,500 | +206.0% | 0.00% | 0.0% |
| Q3 2021 | $419,000 | -43.1% | 34,800 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $736,000 | -24.6% | 34,800 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $976,000 | +1.5% | 34,800 | -5.9% | 0.00% | 0.0% |
| Q4 2020 | $962,000 | -37.8% | 37,000 | -11.1% | 0.00% | -50.0% |
| Q3 2020 | $1,546,000 | -23.5% | 41,600 | +5.6% | 0.00% | -33.3% |
| Q2 2020 | $2,022,000 | +64.0% | 39,400 | +0.8% | 0.01% | +50.0% |
| Q1 2020 | $1,233,000 | -44.7% | 39,100 | +4.5% | 0.00% | -33.3% |
| Q4 2019 | $2,230,000 | +62.7% | 37,400 | 0.0% | 0.01% | +50.0% |
| Q3 2019 | $1,371,000 | -9.3% | 37,400 | +15.1% | 0.00% | 0.0% |
| Q2 2019 | $1,512,000 | +18.4% | 32,500 | +2.2% | 0.00% | 0.0% |
| Q1 2019 | $1,277,000 | +18.7% | 31,800 | +35.9% | 0.00% | 0.0% |
| Q4 2018 | $1,076,000 | +4.1% | 23,400 | +0.4% | 0.00% | +33.3% |
| Q3 2018 | $1,034,000 | +13.3% | 23,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $913,000 | -25.8% | 23,300 | +37.1% | 0.00% | -25.0% |
| Q1 2018 | $1,230,000 | +69.9% | 17,000 | +54.5% | 0.00% | +100.0% |
| Q4 2017 | $724,000 | +31.4% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $551,000 | +8.3% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $509,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |